Five-Year Actual Overall Survival in Resected Pancreatic Cancer: A Contemporary Single-Institution Experience from a Multidisciplinary Perspective
- 4 January 2017
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (6) , 1722-1730
Abstract
Successful surgical resection combined with effective perioperative therapy is essential for maximizing long-term survival for pancreatic adenocarcinoma.Keywords
This publication has 33 references indexed in Scilit:
- Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomesHPB, 2012
- Survival after Resection of Pancreatic Adenocarcinoma: Results from a Single Institution over Three DecadesAnnals of Surgical Oncology, 2011
- Pancreatic Anastomotic Failure Rate after Pancreaticoduodenectomy Decreases with MicrosurgeryJournal of the American College of Surgeons, 2010
- Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031Annals of Oncology, 2010
- Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative StudyAnnals of Surgical Oncology, 2010
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic CancerClinical Cancer Research, 2009
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Adjuvant Radiotherapy and Chemotherapy for Pancreatic Carcinoma: The Mayo Clinic Experience (1975-2005)Journal of Clinical Oncology, 2008
- Multimodality therapy for pancreatic cancer in the U.S.Cancer, 2007
- The Clinical Usefulness of 18-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis, Staging, and Response Evaluation After Concurrent Chemoradiotherapy for Pancreatic CancerJournal of Clinical Gastroenterology, 2006